77 results
8-K
EX-10.3
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
to the jurisdiction of the State of California, and agree that such litigation will be conducted in the courts of San Francisco, California
8-K
EX-10.1
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
of Sections 8 (severance conditions), 11 (assignment), 12 (notices), 13 (confidential information agreement), 15 (litigation cooperation), and 17 (miscellaneous … by or in active planning by the Company or its subsidiaries or affiliates.
15. Litigation and Regulatory Cooperation. During and after the Executive’s
8-K
p56gm 4rxc2t7
27 Nov 23
Regulation FD Disclosure
9:08am
S-8
6eak0d5r9 f6zogx6hf
10 May 23
Registration of securities for employees
4:34pm
8-K
EX-10.1
enudndwsl0
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
8-K
EX-10.1
ws6poryyxzsv 6fas
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm